Mirae Asset Global Investments Co. Ltd. increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 45.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 82,502 shares of the pharmacy operator’s stock after purchasing an additional 25,962 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $794,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Sanctuary Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the second quarter valued at approximately $313,000. Brookstone Capital Management grew its holdings in Walgreens Boots Alliance by 134.2% in the 3rd quarter. Brookstone Capital Management now owns 37,588 shares of the pharmacy operator’s stock worth $337,000 after buying an additional 21,541 shares in the last quarter. CWM LLC increased its position in Walgreens Boots Alliance by 63.8% in the 3rd quarter. CWM LLC now owns 46,161 shares of the pharmacy operator’s stock valued at $414,000 after acquiring an additional 17,980 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Walgreens Boots Alliance by 927.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 13,516 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 12,200 shares in the last quarter. Finally, Gateway Investment Advisers LLC boosted its position in Walgreens Boots Alliance by 9.3% during the 3rd quarter. Gateway Investment Advisers LLC now owns 18,116 shares of the pharmacy operator’s stock worth $162,000 after acquiring an additional 1,534 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.
Wall Street Analysts Forecast Growth
WBA has been the topic of a number of research analyst reports. Jefferies Financial Group lowered their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. UBS Group raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Finally, Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $13.19.
Walgreens Boots Alliance Stock Down 6.1 %
Shares of Walgreens Boots Alliance stock opened at $9.36 on Wednesday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.96. The firm has a market capitalization of $8.09 billion, a PE ratio of -0.91, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65. The stock’s fifty day moving average is $10.24 and its 200-day moving average is $9.79.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the firm earned $0.66 earnings per share. The business’s quarterly revenue was up 7.6% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories
- Five stocks we like better than Walgreens Boots Alliance
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Ride Out The Recession With These Dividend Kings
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.